Mark Garzotto

Professor

  • 3805 Citations
  • 31 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Phytol and its metabolites phytanic and pristanic acids for risk of cancer: Current evidence and future directions

Bobe, G., Zhang, Z., Kopp, R., Garzotto, M., Shannon, J. & Takata, Y., Mar 1 2020, In : European Journal of Cancer Prevention. p. 191-200 10 p.

Research output: Contribution to journalReview article

Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Davis, E. W., Mori, M., Stoller, W. A., Farris, P. E., Wong, C. P., Beaver, L. M., Thomas, G. V., Williams, D. E., Dashwood, R. H., Hendrix, D. A., Ho, E. & Shannon, J., Jan 2 2020, In : Nutrition and Cancer. 72, 1, p. 74-87 14 p.

Research output: Contribution to journalArticle

2 Scopus citations
2019

Dairy product consumption and prostate cancer risk in the United States

Preble, I., Zhang, Z., Kopp, R., Garzotto, M., Bobe, G., Shannon, J. & Takata, Y., Jul 2019, In : Nutrients. 11, 7, 1615.

Research output: Contribution to journalArticle

Open Access

Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: The randomized phase III NRG Oncology RTOG 0521 Trial

Rosenthal, S. A., Hu, C., Sartor, O., Gomella, L. G., Amin, M. B., Purdy, J., Michalski, J. M., Garzotto, M. G., Pervez, N., Balogh, A. G., Rodrigues, G. B., Souhami, L., Reaume, M. N., Williams, S. G., Hannan, R., Horwitz, E. M., Raben, A., Peters, C. A., Feng, F. Y., Shipley, W. U. & 1 others, Sandler, H. M., 2019, In : Journal of Clinical Oncology. 37, 14, p. 1159-1168 10 p.

Research output: Contribution to journalArticle

31 Scopus citations

Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes

Chakiryan, N., Martinez, A., Gao, L., Liu, J. J., Amling, C., Garzotto, M. & Kopp, R. P., Jul 1 2019, In : Journal of Urology. 202, 1, p. 76-81 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

Polymorphisms in oxidative stress pathway genes and prostate cancer risk

Zhang, Z., Jiang, D., Wang, C., Garzotto, M., Kopp, R., Wilmot, B., Thuillier, P., Dang, A., Palma, A., Farris, P. E. & Shannon, J., Dec 1 2019, In : Cancer Causes and Control. 30, 12, p. 1365-1375 11 p.

Research output: Contribution to journalArticle

1 Scopus citations
2018

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M. G., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extension

Mendez, G., Foster, B. R., Li, X., Shannon, J., Garzotto, M., Amling, C. L. & Coakley, F. V., Jul 1 2018, In : Clinical Imaging. 50, p. 280-285 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
4 Scopus citations
2017

Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo

Flamiatos, J. F., Beer, T. M., Graff, J. N., Eilers, K. M., Tian, W., Sekhon, H. S. & Garzotto, M., May 1 2017, In : BJU international. 119, 5, p. 709-716 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates

Bergstrom, C. P., Ruffell, B., Ho, C. M. T., Higano, C. S., Ellis, W. J., Garzotto, M., Beer, T. M. & Graff, J. N., Jan 2017, In : Anti-Cancer Drugs. 28, 1, p. 120-126 7 p.

Research output: Contribution to journalArticle

10 Scopus citations

Is low-risk prostate cancer more indolent in younger patients?

Garzotto, M., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1870-1871 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421

Sonpavde, G., Pond, G. R., Plets, M., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Goldkorn, A., Garzotto, M. G., Mack, P. C., Higano, C. S., Vogelzang, N. J., Thompson, I. M., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P. & Quinn, D. I., Dec 2017, In : Clinical Genitourinary Cancer. 15, 6, p. 635-641 7 p.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Beer, T. M., Thuillier, P., Lieberman, S., Mori, M., Stoller, W. A., Farris, P. E. & Shannon, J., Nov 16 2016, In : Nutrition and Cancer. 68, 8, p. 1309-1319 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Gene-expression profiling of localized prostate cancer: Still miles to go before we sleep

Garzotto, M. & Kopp, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 273-276 4 p.

Research output: Contribution to journalArticle

21 Scopus citations
2015

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

Goldkorn, A., Ely, B., Tangen, C. M., Tai, Y. C., Xu, T., Li, H., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Vogelzang, N. J., Thompson, I. M., Cote, R. J. & Quinn, D. I., Apr 15 2015, In : International Journal of Cancer. 136, 8, p. 1856-1862 7 p.

Research output: Contribution to journalArticle

25 Scopus citations
2014

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Gordon, R. R., Wu, M., Huang, C. Y., Harris, W. P., Sim, H. G., Lucas, J. M., Coleman, I., Higano, C. S., Gulati, R., True, L. D., Vessella, R., Lange, P. H., Garzotto, M., Beer, T. M. & Nelson, P. S., Sep 8 2014, In : PloS one. 9, 9, e104271.

Research output: Contribution to journalArticle

13 Scopus citations

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer

Goldkorn, A., Ely, B., Quinn, D. I., Tangen, C. M., Fink, L. M., Xu, T., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Datar, R. H., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Thompson, I. M., Cote, R. J. & Vogelzang, N. J., Apr 10 2014, In : Journal of Clinical Oncology. 32, 11, p. 1136-1142 7 p.

Research output: Contribution to journalArticle

186 Scopus citations

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer

Barnett, C. M., Heinrich, M. C., Lim, J., Nelson, D., Beadling, C., Warrick, A., Neff, T., Higano, C. S., Garzotto, M., Qian, D., Corless, C. L., Thomas, G. V. & Beer, T. M., 2014, In : Clinical Cancer Research. 20, 5, p. 1306-1312 7 p.

Research output: Contribution to journalArticle

12 Scopus citations
2013

Advances in the Multimodality Management of High-risk Prostate Cancer

Garzotto, M. & Hung, A. Y., Apr 1 2013, In : Surgical Oncology Clinics of North America. 22, 2, p. 375-394 20 p.

Research output: Contribution to journalReview article

1 Scopus citations

Agent Orange as a risk factor for high-grade prostate cancer

Ansbaugh, N., Shannon, J., Mori, M., Farris, P. E. & Garzotto, M., Jul 1 2013, In : Cancer. 119, 13, p. 2399-2404 6 p.

Research output: Contribution to journalArticle

24 Scopus citations

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial

Quinn, D. I., Tangen, C. M., Hussain, M., Lara, P. N., Goldkorn, A., Moinpour, C. M., Garzotto, M. G., Mack, P. C., Carducci, M. A., Monk, J. P., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Higano, C. S., Vogelzang, N. J. & Thompson, I. M., Aug 2013, In : The Lancet Oncology. 14, 9, p. 893-900 8 p.

Research output: Contribution to journalArticle

121 Scopus citations

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

Li, X., Priest, R. A., Woodward, W. J., Tagge, I. J., Siddiqui, F., Huang, W., Rooney, W. D., Beer, T. M., Garzotto, M. G. & Springer, C. S., Jan 2013, In : Magnetic Resonance in Medicine. 69, 1, p. 171-178 8 p.

Research output: Contribution to journalArticle

25 Scopus citations
2012

Benign Prostatic Hyperplasia: A Brief Overview of Pathogenesis, Diagnosis, and Therapy

Priest, R., Garzotto, M. & Kaufman, J., Dec 1 2012, In : Techniques in Vascular and Interventional Radiology. 15, 4, p. 261-264 4 p.

Research output: Contribution to journalArticle

21 Scopus citations

Cell membrane water exchange effects in prostate DCE-MRI

Li, X., Priest, R. A., Woodward, W. J., Siddiqui, F., Beer, T. M., Garzotto, M. G., Rooney, W. D. & Springer, C. S., May 2012, In : Journal of Magnetic Resonance. 218, p. 77-85 9 p.

Research output: Contribution to journalArticle

19 Scopus citations
2011

Androgen deprivation therapy for prostate cancer: Not so simple

Tadros, N. N. & Garzotto, M., Mar 2011, In : Asian Journal of Andrology. 13, 2, p. 187-188 2 p.

Research output: Contribution to journalComment/debate

4 Scopus citations

Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization

Hung, A. Y., Garzotto, M. & Kaurin, D., Jan 1 2011, In : Medical Dosimetry. 36, 2, p. 195-199 5 p.

Research output: Contribution to journalArticle

10 Scopus citations
2010

Acupuncture for hot flashes in patients with prostate cancer

Beer, T. M., Benavides, M., Emmons, S. L., Hayes, M., Liu, G., Garzotto, M., Donovan, D., Katovic, N., Reeder, C. & Eilers, K., Nov 2010, In : Urology. 76, 5, p. 1182-1188 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity

Qian, D. Z., Rademacher, B. L. S., Pittsenbarger, J., Huang, C. Y., Myrthue, A., Higano, C. S., Garzotto, M., Nelson, P. S. & Beer, T. M., Mar 1 2010, In : Prostate. 70, 4, p. 433-442 10 p.

Research output: Contribution to journalArticle

70 Scopus citations

Contemporary management of high-risk localized prostate cancer

Garzotto, M. & Hung, A. Y., May 1 2010, In : Current urology reports. 11, 3, p. 159-164 6 p.

Research output: Contribution to journalReview article

11 Scopus citations

Editorial comment

Garzotto, M., Jun 17 2010, In : Journal of Urology. 184, 2, 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Editorial Comment

Garzotto, M., Jan 2010, In : Journal of Urology. 183, 1, p. 123-124 2 p.

Research output: Contribution to journalComment/debate

Erratum: ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21 (Cancer Research (2010) 70, (3239-3248) DOI:10.1158/0008-5472. CAN-09-3186)

Geng, H., Rademacher, B. L., Pittsenbarger, J., Huang, C. Y., Harvey, C. T., Lafortune, M. C., Myrthue, A., Garzotto, M., Nelson, P. S., Beer, T. M. & Qian, D. Z., Jun 1 2010, In : Cancer Research. 70, 11, 1 p.

Research output: Contribution to journalComment/debate

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods

Shannon, J., O'Malley, J., Mori, M., Garzotto, M., Palma, A. J. & King, I. B., Sep 2010, In : Prostaglandins Leukotrienes and Essential Fatty Acids. 83, 3, p. 161-169 9 p.

Research output: Contribution to journalArticle

20 Scopus citations

Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer

O'Brien, C., True, L. D., Higano, C. S., Rademacher, B. L. S., Garzotto, M. & Beer, T. M., Apr 2010, In : American journal of clinical pathology. 133, 4, p. 654-661 8 p.

Research output: Contribution to journalArticle

35 Scopus citations

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21

Geng, H., Rademacher, B. L., Pittsenbarger, J., Huang, C. Y., Harvey, C. T., Lafortune, M. C., Myrthue, A., Garzotto, M., Nelson, P. S., Beer, T. M. & Qian, D. Z., Apr 15 2010, In : Cancer Research. 70, 8, p. 3239-3248 10 p.

Research output: Contribution to journalArticle

27 Scopus citations

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer

Garzotto, M., Higano, C. S., O'Brien, C., Rademacher, B. L. S., Janeba, N., Fazli, L., Lange, P. H., Lieberman, S. & Beer, T. M., Apr 1 2010, In : Cancer. 116, 7, p. 1699-1708 10 p.

Research output: Contribution to journalArticle

36 Scopus citations

Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer

Zhu, M. L., Horbinski, C. M., Garzotto, M., Qian, D. Z., Beer, T. M. & Kyprianou, N., Oct 15 2010, In : Cancer Research. 70, 20, p. 7992-8002 11 p.

Research output: Contribution to journalArticle

256 Scopus citations
2009

Folate intake and prostate cancer risk: A case-control study

Shannon, J., Phoutrides, E., Palma, A., Farris, P., Peters, L., Forester, A., Tillotson, C. J. & Garzotto, M., Sep 1 2009, In : Nutrition and Cancer. 61, 5, p. 617-628 12 p.

Research output: Contribution to journalArticle

31 Scopus citations

Lower urinary tract symptoms increase the risk of falls in older men

Parsons, J. K., Mougey, J., Lambert, L., Wilt, T. J., Fink, H. A., Garzotto, M., Barrett-Connor, E. & Marshall, L. M., Jul 2009, In : BJU international. 104, 1, p. 63-68 6 p.

Research output: Contribution to journalArticle

111 Scopus citations

Prostate cancer - Associated gene expression alterations determined from needle biopsies

Qian, D. Z., Huang, C. Y., O'Brien, C. A., Coleman, I. M., Garzotto, M., True, L. D., Higano, C. S., Vessella, R., Lange, P. H., Nelson, P. S. & Beer, T. M., May 1 2009, In : Clinical Cancer Research. 15, 9, p. 3135-3142 8 p.

Research output: Contribution to journalArticle

13 Scopus citations
2008

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

Chan, J. S., Beer, T. M., Quinn, D. I., Pinski, J. K., Garzotto, M., Sokoloff, M., Dehaze, D. R. & Ryan, C. W., Dec 2008, In : BJU international. 102, 11, p. 1601-1606 6 p.

Research output: Contribution to journalArticle

31 Scopus citations

Reply to neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

Sonpavde, G., Garzotto, M. & Chi, K. N., Jun 1 2008, In : Cancer. 112, 11, p. 2519 1 p.

Research output: Contribution to journalLetter

The natural and treated history of prostate cancer

Garzotto, M., Jan 1 2008, Prostate Cancer. Cambridge University Press, p. 15-28 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

Montgomery, B., Lavori, P., Garzotto, M., Lee, K., Brophy, M., Thaneemit-Chen, S., Kelly, W., Basler, J., Ringer, R., Yu, W., Whittemore, A. & Lin, D. W., Sep 1 2008, In : Urology. 72, 3, p. 474-480 7 p.

Research output: Contribution to journalReview article

17 Scopus citations
2007

Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy

Spurgeon, S. E. F., Mongoue-Tchokote, S., Collins, L., Priest, R., Hsieh, Y. C., Peters, L. M., Beer, T. M., Mori, M. & Garzotto, M., May 1 2007, In : Urology. 69, 5, p. 931-935 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Diethylstilbestrol and docetaxel: A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

Montgomery, R. B., Nelson, P. S., Lin, D., Ryan, C. W., Garzotto, M. & Beer, T. M., Sep 1 2007, In : Cancer. 110, 5, p. 996-1002 7 p.

Research output: Contribution to journalArticle

18 Scopus citations